N O T IZ E
18 M. A. S t a h m a n n , J. S . F r u t o n u. M. B e r g m a n n , J. biol. Che mistry 164, 753 [1946] . Riboflavin concentration appears considerably dimi nished in neoplastic tissues: this vitamin is able to develop some protective action on the liver of animals fed with diets containing oncogenic substances1. As Mepacrine or Quinacrine 2-chloro-5-(cü-diethylamino-amethylbuthylamino)-7-methoxyacridine, well known antimalariae drug, exerts a riboflavin sparing action in animals treated with suboptimal doses of such vitamine2, a research was carried in order to value mepa-1 Y . M a is in g , G . L a m p e r t , L . D ec k e r -P a s s a u u . F. M a l d a g u e , Acta Union Internationale Contre Cancer 13, 804 [1957] . 2 K. G u g g e n h e im , R. S h a m ir -Z e m ik , J. biol. Chemistry 2 0 2 , 331 [1953] .
crine effect on liver contents of riboflavin during car cinogenesis by iV,2-fluorenylacetamide. To this purpose, 120 young white rats, taken from a stock whose liver average contents was determined in pig. 27.9/g. fresh liver (Range 25.2 -30.4; S.E. 2.28), were fed with the following basal diet: casein vitamin free 15%, corn oil 7%, salt mixture IV 5%, vitamins in lactose 5%, sucrose q.s. to 100 g.
Corn oil contained 40 U/ml vitamin A and 100 U/ml vitamin D2 .
In the lactose there were all the other vitamins, among which riboflavin at a level of mg. 12.5/100 g. vitaminized lactose, equal to jug 625/100 g. of basal ration; the animals fed on suboptimal doses received in lactose mg. 1.25/100 g. of vitaminized lactose, equal to pig 62.5/100 g. of riboflavine basal ration.
Some rats received contemporaneously mepacrine at a level of 0.05% in basal ration and or V,2-fluorenylacetamide at a level of 0.06%.
Variation of these substances in the diet are sum marised on The obtained data show that mepacrine is really able to repress fall of liver riboflavin either in animals sub mitted to vitamin B2 deficient diet, or during carcino genesis in presence or not of riboflavin optimal doses.
A certain difference in the liver weight occurred in various groups of animals: in the rats kept on normal diet and /V,2-fluorenylacetamide, the organ weight after 21 weeks was of 7.41% in opposition to 8.22% in animals fed with vitamin B2 suboptimal doses; in ani mals with an additional diet of mepacrine the liver weight was of 6.67% in presence of vitamin B2 optimal doses and of 7.72% in the rats fed with suboptimal doses.
As it is not imputable to mepacrine any particular action on liver, when employed at the above said doses, it seems logical to think that its effect is chiefly due to the interference on riboflavinic metabolism; yet it is known that mepacrine, given to rats3, reaches an excep tionally high concentration in their livers. It is possible that mepacrine, owing to its structural analogy to vit amin B2, can partially replace riboflavin in some fla vine containing enzyme, or act by means of inhibition of metabolic destruction process of the vitamin or of some of its conjugated.
Higher riboflavin contents during carcinogenesis could have as consequence a smaller fall of the action of those enzymatic system whose normal action requires this vitamins.
